Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development

Curr Trop Med Rep. 2015 Sep 1;2(3):171-180. doi: 10.1007/s40475-015-0054-y.

Abstract

Cryptosporidium spp is a major cause of diarrheal disease worldwide, particularly in malnourished children and untreated AIDS patients in developing countries in whom it can cause severe, chronic and debilitating disease. Unfortunately, there is no consistently effective drug for these vulnerable populations and no vaccine, partly due to a limited understanding of both the parasite and the host immune response. In this review, we will discuss our current understanding of the systemic and mucosal immune responses to Cryptosporidium infection, discuss the feasibility of developing a Cryptosporidium vaccine and evaluate recent advances in Cryptosporidium vaccine development strategies.

Keywords: Cryptosporidium; immune response; mucosal; vaccine.